The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Open accessAbstract
The combination of the scaffolds of the cholinesterase inhibitor huprine Y and the antioxidant capsaicin results in compounds with nanomolar potencies toward human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) that retain or improve the antioxidant properties of capsaicin. Crystal structures of their complexes with AChE and BChE revealed the molecular basis for their high potency. Brain penetration was confirmed by biodistribution studies in C57BL6 mice, with one compound ( 5i ) displaying better brain/plasma ratio than donepezil. Chronic treatment of 10 month-old APP/PS1 mice with 5i (2 mg/kg, i.p., 3 times per week, 4 weeks) rescued learning and memory impairments, as measured by three different behavioral tests, delayed the Alzheimer-like pathology progression, as suggested by a significantly reduced Aβ42/Aβ40 ratio in the hippocampus, improved basal synaptic efficacy, and significantly reduced hippocampal oxidative stress and neuroinflammation. Compound 5i emerges as an interesting anti-Alzheimer lead with beneficial effects on cognitive symptoms and on some underlying disease mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
Use of a Free Radical Method to Evaluate Antioxidant Activity
Brand-Williams, W., Cuvelier, M. E., & Berset, C. (1995) · LWT - Food Science and Technology · doi:10.1016/s0023-6438(95)80008-5 · Cited by 25,994
The Chemistry behind Antioxidant Capacity Assays
Huang, D., Ou, B., & Prior, R. L. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf030723c · Cited by 6,162
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
The open-field test: A critical review.
WALSH, R. N., & Cummins, R. A. (1976) · Psychological Bulletin · doi:10.1037//0033-2909.83.3.482 · Cited by 2,506
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668
Bevins, R. A., & Besheer, J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.205 · Cited by 1,277
High throughput artificial membrane permeability assay for blood–brain barrier
Di, L., Kerns, E. H., Fan, K., McConnell, O. J., & Carter, G. T. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00012-6 · Cited by 1,195
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Research works printed but not linked: 3
- Camps P., 2000, Mol. Pharmacol., 57, 409
- Taylor P., 1974, Mol. Pharmacol., 10, 703
- 10.1037/0033-2909.83.3.482 · doi:10.1037/0033-2909.83.3.482 · Paper page
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“530 Given the elevated activity of monoamine oxidase-B (MAO-B) observed in AD, dual inhibition of AChE and MAO-B holds promise for synergistic effects on cholinergic system recovery and A β plaque formation, along with potential bene fi ts in alleviating oxidative stress injury.”
BackgroundSustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer’s Disease
Rossi, M., Freschi, M., Nascente, L. D. C., Salerno, A., Teixeira, S. D. M. V., Nachon, F., Chantegreil, F., Soukup, O., Prchal, L., Malaguti, M., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00048 · Cited by 147
Self-citationCodony, S., Pont, C., Griñán‐Ferré, C., Pede-Mattatelli, A. D., Calvó‐Tusell, C., Feixas, F., Osuna, S., Jarné‐Ferrer, J., Naldi, M., Bartolini, M., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02150 · Cited by 61
Self-citationTacrine-Based Hybrids: Past, Present, and Future
Bubley, A., Erofeev, A. S., Gorelkin, P. V., Beloglazkina, E. K., Majouga, A. G., & Krasnovskaya, O. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021717 · Cited by 52
Click chemistry-aided drug discovery: A retrospective and prospective outlook
Zhao, R., Zhu, J., Jiang, X., & Bai, R. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116037 · Cited by 48
Metadata
- Authors
- Viayna, E., Coquelle, N., Cieslikiewicz-Bouet, M., Cisternas, P., Oliva, C. A., Sánchez-López, E., Ettcheto, M., Bartolini, M., De Simone, A., Ricchini, M., Rendina, M., Pons, M., Firuzi, O., Pérez, B., Saso, L., Andrisano, V., Nachon, F., Brazzolotto, X., García, M. L., Camins, A., Silman, I., Jean, L., Inestrosa, N. C., Colletier, J.-P., Renard, P.-Y., & Muñoz-Torrero, D.
- Affiliations
- Institut de Biomedicina de la Universitat de Barcelona (ES)
- Centre National de la Recherche Scientifique (FR)
- Normandie University, UNIROUEN, INSA Rouen, CNRS, COBRA (UMR 6014), 76000 Rouen, France
- Pontificia Universidad Católica de Chile (CL)
- Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain
- Instituto de Salud Carlos III (ES)
- University of Bologna (IT)
- Department of Drug Science and Technology, University of Turin, I-10125 Torino, Italy
- Shiraz University of Medical Sciences (IR)
- Universitat Autònoma de Barcelona (ES)
- Sapienza University of Rome (IT)
- Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées BP73, 91993 Brétigny sur Orge, France
- Weizmann Institute of Science (IL)
- Laboratory of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain
- Corresponding author
- Inestrosa, Nibaldo C.
- Colletier, Jacques-Philippe
- Renard, Pierre-Yves
- ORCID
- Viayna, Elisabet
- Coquelle, Nicolas
- Cisternas, Pedro
- Oliva, Carolina A.
- Ettcheto, Miren
- Bartolini, Manuela
- Firuzi, Omidreza
- Pérez, Belén
- Saso, Luciano
- Andrisano, Vincenza
- Nachon, Florian
- Brazzolotto, Xavier
- García, Maria Luisa
- Camins, Antoni
- Silman, Israel
- Jean, Ludovic
- Inestrosa, Nibaldo C.
- Colletier, Jacques-Philippe
- Renard, Pierre-Yves
- Muñoz-Torrero, Diego
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-12-28
- Volume
- 64
- Issue
- 1
- Pages
- 812-839
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3113989042
- Cited by
- 106
- References
- 101
- Citations by year
- 2026: 20 · 2025: 24 · 2024: 21 · 2023: 19 · 2022: 13 · 2021: 9
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-12-BS07-0008-01)
- Ministry of Science, Innovation and Universities (SAF2014-57094-R, SAF2017-82771-R)
- Generalitat de Catalunya (2017SGR106)
- Alzheimer Nadacn?? Fond (FA-AAP-2013-65-101349)
- Fondo Nacional de Desarrollo Cient??fico y Tecnol??gico (11160651)
- MIADES (T010131, T010132)
- Ministero dell'Istruzione, dell'Universit?? e della Ricerca
- Agencia Estatal de Investigaci??n (SAF2014-57094-R, SAF2017-82771-R)
- FEDER (SAF2014-57094-R, SAF2017-82771-R)
- Basal Center of Excellence in Aging and Regeneration (CONICYT-AFB 170005)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pesticide Exposure and Toxicity
- Keywords
- capsaicin, antioxidant activity, Alzheimer's disease, APP/PS1 mice, amyloid-beta 42/40 ratio, neuroinflammation, synaptic efficacy, learning and memory impairment, brain penetration, crystal structure
- MeSH terms
- Acetylcholinesterase, Alzheimer Disease, Amyloid, Animals, Antioxidants, Binding Sites, Brain, Butyrylcholinesterase, Cholinesterase Inhibitors, Disease Models, Animal, Drug Evaluation, Preclinical, Humans, Male, Mice, Inbred C57BL, Structure-Activity Relationship, Tissue Distribution, Aspartic Acid Endopeptidases, Oxidative Stress, Mice, Amyloid Precursor Protein Secretases, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice. https://app.cochat.ai/papers/10.1021/acs.jmedchem.0c01775
- The paper
- Viayna, E., Coquelle, N., Cieslikiewicz-Bouet, M., Cisternas, P., Oliva, C. A., Sánchez-López, E., Ettcheto, M., Bartolini, M., De Simone, A., Ricchini, M., Rendina, M., Pons, M., Firuzi, O., Pérez, B., Saso, L., Andrisano, V., Nachon, F., Brazzolotto, X., García, M. L., . . . Muñoz-Torrero, D. (2021). Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.0c01775
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.